MoneyWorks4Me

Parmax Pharma informs about proceedings of AGM

21 Sep 2021 Evaluate

Parmax Pharma has informed that it enclosed summary of the proceedings as required under Regulation 30, Part-A of Schedule-III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations with respect to 27th Annual General Meeting (AGM) of the company held on Monday, 20th September, 2021 at 2:00 pm till 3.00 pm at the registered office of the company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..